What the brain teaches us about latent inhibition (LI): The neural substrates of the expression and prevention of LI

Latent Inhibition: Cognition, Neuroscience and Applications to Schizophrenia

Volumn , Issue , 2010, Pages 372-416

  Weiner, Ina ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84926117542     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511730184.017     Document Type: Chapter

References (286)

1. Ackil, J., Mellgren, R. L., Halgren, C., & Frommer, S. P. (1969). Effects of CS preexposure on avoidance learning in rats with hippocampal lesions. Journal of Comparative and Physiological Psychology, 69, 739-747.
2. Aggleton, J. P., Neave, N., Nagle, S., & Sahgal, A. (1995). A comparison of the effects of medial prefrontal, cingulate cortex, and cingulum bundle lesions on tests of spatial memory: evidence of a double dissociation between frontal and cingulum bundle contributions. The Journal of Neuroscience, 15, 7270-7281.
3. Angrist, B., Rotrosen, J., & Gershon, S. (1980). Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects. Psychopharmacology (Berl.), 67, 31-38.
4. Angrist, B., Sathananthan, G., Wilk, S.,&Gershon, S. (1974). Amphetamine psychosis: behavioral and biochemical aspects. Journal of Psychiatric Research, 11, 13-23.
5. Angrist, B. M., Shopsin, B., & Gershon, S. (1971). Comparative psychotomimetic effects of stereoisomers of amphetamine. Nature, 234, 152-153.
6. Anscombe, R. (1987). The disorder of consciousness in schizophrenia. Schizophrenia Bulletin, 13, 241-260.
7. Arnt, J., & Skarsfeldt, T. (1998). Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology, 18, 63-101.
8. Asarnow, R. F., Marder, S. R., Mintz, J., Van Putten, T., & Zimmerman, K. E. (1988). Differential effect of low and conventional doses of fluphenazine on schizophrenic outpatients with good or poor information-processing abilities. Archives of General Psychiatry, 45, 822-826.
9. Bakshi, V. P., Geyer, M. A., Taaid, N., & Swerdlow, N. R. (1995). A comparison of the effects of amphetamine, strychnine and caffeine on prepulse inhibition and latent inhibition. Behavioural Pharmacology, 6, 801-809.
10. Baruch, I., Hemsley, D. R., & Gray, J. A. (1988a). Differential performance of acute and chronic schizophrenics in a latent inhibition task. The Journal of Nervous and Mental Disease, 176, 598-606.
11. Baruch, I., Hemsley, D. R., & Gray, J. A. (1988b). Latent inhibition and 'psychotic proneness' in normal subjects. Personality and Individual Differences, 9, 777-783.
12. Bassareo, V., & Di Chiara, G. (1999). Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience, 89, 637-641.
13. Baxter, M. G., Parker, A., Lindner, C. C., Izquierdo, A. D., & Murray, E. A. (2000). Control of response selection by reinforcer value requires interaction of amygdala and orbital prefrontal cortex. The Journal of Neuroscience, 20, 4311-4319.
14. Beckmann, H., & Jakob, H. (1991). Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? Journal of Neural Transmission. General Section, 84, 155-164.
15. Berendse, H. W., Groenewegen, H. J., & Lohman, A. H. (1992). Compartmental distribution of ventral striatal neurons projecting to the mesencephalon in the rat. The Journal of Neuroscience, 12, 2079-2103.
16. Birrell, J. M., & Brown, V. J. (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. The Journal of Neuroscience, 20, 4320-4324.
17. Bleuler, M. (1911). Dementia Praecox or the Group of Schizophrenias. New York: International Universities Press.
18. Bogerts, B. (1991). The neuropathology of schizophrenia: pathophysiological and neurodevelopmental implications. In S. A. Mednick, T. D. Cannon, C. E. Barr & M. Lyon (Eds.), Fetal Neural Development and Adult Schizophrenia. Cambridge: Cambridge University Press, pp. 153-173.
19. Bogerts, B. (1993). Recent advances in the neuropathology of schizophrenia. Schizophrenia Bulletin, 19, 431-445.
20. Bogerts, B., Meertz, E., & Schonfeldt-Bausch, R. (1985). Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Archives of General Psychiatry, 42, 784-791.
21. Bouton, M. E. (1993). Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychological Bulletin, 114, 80-99.
22. Braff, D. L., & Saccuzzo, D. P. (1982). Effect of antipsychotic medication on speed of information processing in schizophrenic patients. American Journal of Psychiatry, 139, 1127-1130.
23. Braunstein-Bercovitz, H., & Lubow, R. E. (1998). Are high-schizotypal normal participants distractible or limited in attentional resources? A study of latent inhibition as a function of masking task load and schizotypy level. Journal of Abnormal Psychology, 107, 659-670.
24. Broen, W. E. (1968). Schizophrenia: Research and Theory. New York: Academic Press.
25. Broersen, L. M., Feldon, J., & Weiner, I. (1999). Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience, 94, 39-46.
26. Broersen, L. M., Heinsbroek, R. P., de Bruin, J. P., & Olivier, B. (1996). Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition. Biological Psychiatry, 40, 1083-1090.
27. Brown, V. J., & Bowman, E. M. (2002). Rodent models of prefrontal cortical function. Trends in Neurosciences, 25, 340-343.
28. Buhusi, C. V., Gray, J. A., & Schmajuk, N. A. (1998). Perplexing effects of hippocampal lesions on latent inhibition: a neural network solution. Behavioral Neuroscience, 112, 316-351.
29. Cadoni, C., Solinas, M., & Di Chiara, G. (2000). Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. European Journal of Pharmacology, 388, 69-76.
30. Cador, M., Robbins, T.W., Everitt, B. J., et al. (1991). Limbic-striatal interactions in reward-related processes: modulation by the dopaminergic system. In P. Willner & J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action. Chichester: John Wiley, pp. 225-250.
31. Cardinal, R. N., Parkinson, J. A., Hall, J., & Everitt, B. J. (2002). Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neuroscience & Biobehavioral Reviews, 26, 321-352.
32. Carlsson, M., & Carlsson, A. (1990). Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin, 16, 425-432.
33. Cassaday, H. J., Mitchell, S. N., Williams, J. H., & Gray, J. A. (1993). 5,7-Dihydroxytryptamine lesions in the fornix-fimbria attenuate latent inhibition. Behavioral and Neural Biology, 59, 194-207.
34. Christison, G. W., Atwater, G. E., Dunn, L. A., & Kilts, C. D. (1988). Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biological Psychiatry, 23, 746-749.
35. Clark, A. J., Feldon, J., & Rawlins, J. N. (1992). Aspiration lesions of rat ventral hippocampus disinhibit responding in conditioned suppression or extinction, but spare latent inhibition and the partial reinforcement extinction effect. Neuroscience, 48, 821-829.
36. Cools, A. R., Coolen, J. M., Smit, J. C., & Ellenbroek, B. A. (1984). The striatonigro- collicular pathway and explosive running behaviour: functional interaction between neostriatal dopamine and collicular GABA. European Journal of Pharmacology, 100, 71-77.
37. Cornblatt, B., & Erlenmeyer-Kimling, L. (1984). Early attentional predictors of adolescent behavioral disturbances in children at risk for schizophrenia. In N. F. Watt, E. F. Anthony, L. C. Wynne, & J. E. Rolf (Eds.), Children at Risk for Schizophrenia: A Longitudinal Perspective. New York: Cambridge University Press.
38. Cornblatt, B. A., Lenzenweger, M. F., Dworkin, R. H., & Erlenmeyer-Kimling, L. (1985). Positive and negative schizophrenic symptoms, attention, and information processing. Schizophrenia Bulletin, 11, 397-408.
39. Cornblatt, B., Winters, L., & Erlenmeyer-Kimling, L. (1989). Attentional markers of schizophrenia: evidence from the New York high-risk study. In S. C. Schulz & C. A. Tamminga (Eds.), Schizophrenia: Scientific Progress. New York: Oxford University Press, pp. 83-92.
40. Coutureau, E., Blundell, P. J., & Killcross, S. (2001). Basolateral amygdala lesions disrupt latent inhibition in rats. Brain Research Bulletin, 56, 49-53.
41. Coutureau, E., Galani, R., Gosselin, O., Majchrzak, M., & Di Scala, G. (1999). Entorhinal but not hippocampal or subicular lesions disrupt latent inhibition in rats. Neurobiology of Learning and Memory, 72, 143-157.
42. Coutureau, E., Gosselin, O., & Di Scala, G. (2000). Restoration of latent inhibition by olanzapine but not haloperidol in entorhinal cortex-lesioned rats. Psychopharmacology (Berl.), 150, 226-232.
43. Coutureau, E., Lena, I., Dauge, V., & Di, S. G. (2002). The entorhinal cortex-nucleus accumbens pathway and latent inhibition: a behavioral and neurochemical study in rats. Behavioral Neuroscience, 116, 95-104.
44. Csernansky, J. G., Murphy, G. M., & Faustman, W. O. (1991). Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biological Psychiatry, 30, 383-400.
45. de Bruin, J. P., Sanchez-Santed, F., Heinsbroek, R. P., Donker, A., & Postmes, P. (1994). A behavioural analysis of rats with damage to the medial prefrontal cortex using the Morris water maze: evidence for behavioural flexibility, but not for impaired spatial navigation. Brain Research, 652, 323-333.
46. De la Casa, L. G., & Lubow, R. E. (1994). Memory for attended and nominally unattended stimuli in low and high psychotic-prone normal subjects: the effects of test-anticipation. Personality and Individual Differences, 17, 783-789.
47. De la Casa, L. G., Ruiz, G., & Lubow, R. E. (1993). Latent inhibition and recall/recognition of irrelevant stimuli as a function of pre-exposure duration in high and low psychotic-prone normal subjects. British Journal of Psychology, 84, 119-132.
48. Della Casa, V., Hofer, I., Weiner, I., & Feldon, J. (1999). Effects of smoking status and schizotypy on latent inhibition. Journal of Psychopharmacology, 13, 45-57.
49. Deutch, A. Y. (1993). Prefrontal cortical dopamine systems and the elaboration of functional corticostriatal circuits: implications for schizophrenia and Parkinson's disease. Journal of Neural Transmission. General Section, 91, 197-221.
50. Deutch, A. Y., & Cameron, D. S. (1992). Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience, 46, 49-56.
51. Di Chiara, G. (1995). The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug and Alcohol Dependence, 38, 95-137.
52. Dias, R., & Aggleton, J. P. (2000). Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility. The European Journal of Neuroscience, 12, 4457-4466.
53. Dias, R., Robbins, T. W., & Roberts, A. C. (1996). Dissociation in prefrontal cortex of affective and attentional shifts. Nature, 380, 69-72.
54. Dias, R., Robbins, T. W., & Roberts, A. C. (1997). Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing. The Journal of Neuroscience, 17, 9285-9297.
55. Dunn, L. A., Atwater, G. E., & Kilts, C. D. (1993). Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology (Berl.), 112, 315-323.
56. Ellenbroek, B. A., Budde, S., & Cools, A. R. (1996). Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience, 75, 535-542.
57. Ellenbroek, B. A., & Cools, A. R. (1990). Animal models with construct validity for schizophrenia. Behavioural Pharmacology, 1, 469-490.
58. Ellenbroek, B. A., Knobbout, D. A., & Cools, A. R. (1997). The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm. Psychopharmacology (Berl.), 129, 112-120.
59. Everitt, B., & Robbins, T. W. (1992). Amygdala-ventral striatal interactions and reward-related processes. In J. P. Aggleton (Ed.), The Amygdala. Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. Oxford: John Wiley and Sons, pp. 401-429.
60. Fanselow, M. S., & LeDoux, J. E. (1999). Why we think plasticity underlying Pavlovian fear conditioning occurs in the basolateral amygdala. Neuron, 23, 229-232.
61. Feldon, J., & Weiner, I. (1991). Effects of haloperidol on the multitrial partial reinforcement extinction effect (PREE): evidence for neuroleptic drug action on nonreinforcement but not on reinforcement. Psychopharmacology (Berl.), 105, 407-414.
62. Fendt, M., & Fanselow, M. S. (1999). The neuroanatomical and neurochemical basis of conditioned fear. Neuroscience & Biobehavioral Reviews, 23, 743-760.
63. Floresco, S. B., Blaha, C. D., Yang, C. R., & Phillips, A. G. (2001). Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection. The Journal of Neuroscience, 21, 2851-2860.
64. Frey, P. W., & Sears, R. G. (1978). Model of conditioning incorporating the Rescorla-Wagner associative axiom, a dynamic attention process, and a catastrophe rule. Psychological Review, 85, 321-341.
65. Frith, C. D. (1979). Consciousness, information processing and schizophrenia. The British Journal of Psychiatry, 134, 225-235.
66. Gal, G. (2000). Disrupted and undisruptable latent inhibition following shell and core lesions: the dual role of the nucleus accumbens in latent inhibition. Tel Aviv University, Tel Aviv.
67. Gal, G., Schiller, D., & Weiner, I. (2005). Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: the neural site controlling the expression and disruption of the stimulus preexposure effect. Behavioural Brain Research, 162, 246-255.
68. Gallagher, M., & Chiba, A. A. (1996). The amygdala and emotion. Current Opinion in Neurobiology, 6, 221-227.
69. Gallagher, M., McMahan, R. W., & Schoenbaum, G. (1999). Orbitofrontal cortex and representation of incentive value in associative learning. The Journal of Neuroscience, 19, 6610-6614.
70. Gallagher, M., & Schoenbaum, G. (1999). Functions of the amygdala and related forebrain areas in attention and cognition. Annals of the New York Academy of Sciences, 877, 397-411.
71. Gelissen, M., & Cools, A. (1988). Effect of intracaudate haloperidol and apomorphine on switching motor patterns upon current behaviour of cats. Behavioural Brain Research, 29, 17-26.
72. Gjerde, P. F. (1983). Attentional capacity dysfunction and arousal in schizophrenia. Psychological Bulletin, 93, 57-72.
73. Gosselin, G., Oberling, P., & Di Scala, G. (1996). Antagonism of amphetamineinduced disruption of latent inhibition by the atypical antipsychotic olanzapine in rats. Behavioural Pharmacology, 7, 820-826.
74. Grace, A. A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24.
75. Grace, A. A. (2000). Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Research. Brain Research Reviews, 31, 330-341.
76. Gray, J. A., Feldon, J., Rawlins, J. N. P., Hemsley, D. R., & Smith, A. D. (1991). The neuropsychology of schizophrenia. Behavioral and Brain Sciences, 14, 1-20.
77. Gray, J. A., Joseph, M.H., Hemsley, D. R., et al. (1995a). The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behavioural Brain Research, 71, 19-31.
78. Gray, J. A., Moran, P. M., Grigoryan, G., et al. (1997). Latent inhibition: the nucleus accumbens connection revisited. Behavioural Brain Research, 88, 27-34.
79. Gray, N. S., Hemsley, D. R., & Gray, J. A. (1992a). Abolition of latent inhibition in acute, but not chronic schizophrenics. Neurology, Psychiatry and Brain Research, 1, 83-89.
80. Gray, N. S., Pickering, A. D., Hemsley, D. R., Dawling, S., & Gray, J. A. (1992b). Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology (Berl.), 107, 425-430.
81. Gray, N. S., Pilowsky, L. S., Gray, J. A., & Kerwin, R. W. (1995b). Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET. Schizophrenia Research, 17, 95-107.
82. Groenewegen, H. J., Berendse, H.W., Meredith, G. E., et al. (1991). Functional anatomy of the ventral, limbic system-innervated striatum. In P. Willner & J. Scheel-Kruger (Eds.), The Mesolimbic Dopamine System: From Motivation to Action. Chichester: John Wiley, pp. 19-60.
83. Groenewegen, H. J., Vermeulen-Van der Zee, E., te Kortschot, A., & Witter, M. P. (1987). Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience, 23, 103-120.
84. Groenewegen, H. J., Wright, C. I., & Beijer, A. V. (1996). The nucleus accumbens: gateway for limbic structures to reach the motor system? Progress in Brain Research, 107, 485-511.
85. Groenewegen, H. J., Wright, C. I., Beijer, A. V., & Voorn, P. (1999). Convergence and segregation of ventral striatal inputs and outputs. Annals of the New York Academy of Sciences, 877, 49-63.
86. Hall, G., & Channell, S. (1985). Latent inhibition and conditioning after pre-exposure to the training context. Learning and Motivation, 16, 381-397.
87. Hall, R. C., Popkin, M. K., Beresford, T. P., & Hall, A. K. (1988). Amphetamine psychosis: Clinical presentations and differential diagnosis. Psychiatric Medicine, 6, 73-79.
88. Han, J. S., Gallagher, M., & Holland, P. (1995). Hippocampal lesions disrupt decrements but not increments in conditioned stimulus processing. The Journal of Neuroscience, 15, 7323-7329.
89. Harrison, P. J. (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain, 122, 593-624.
90. Hatfield, T., Han, J. S., Conley, M., Gallagher, M., & Holland, P. (1996). Neurotoxic lesions of basolateral, but not central, amygdala interfere with Pavlovian second-order conditioning and reinforcer devaluation effects. The Journal of Neuroscience, 16, 5256-5265.
91. Heimer, L., Alheid, G. F., de Olmos, J. S., et al. (1997). The accumbens: Beyond the core-shell dichotomy. The Journal of Neuropsychiatry and Clinical Neurosciences, 9, 354-381.
92. Hemsley, D. R. (1993). A simple (or simplistic?) cognitive model for schizophrenia. Behaviour Research and Therapy, 31, 633-645.
93. Hemsley, D. R. (1994). Cognitive disturbance as the link between schizophrenic symptoms and their biological bases. Neurology Psychiatry and Brain Research, 2, 163-170.
94. Holland, P. C., & Gallagher, M. (1999). Amygdala circuitry in attentional and representational processes. Trends in Cognitive Sciences, 3, 65-73.
95. Holt, W., & Maren, S. (1999). Muscimol inactivation of the dorsal hippocampus impairs contextual retrieval of fear memory. The Journal of Neuroscience, 19, 9054-9062.
96. Honey, R. C., & Good, M. (1993). Selective hippocampal lesions abolish the contextual specificity of latent inhibition and conditioning. Behavioral Neuroscience, 107, 23-33.
97. Howland, J. G., Taepavarapruk, P., & Phillips, A. G. (2002). Glutamate receptordependent modulation of dopamine efflux in the nucleus accumbens by basolateral, but not central, nucleus of the amygdala in rats. The Journal of Neuroscience, 22, 1137-1145.
98. Hutcheson, D.M., Parkinson, J. A., Robbins, T. W., & Everitt, B. J. (2001). The effects of nucleus accumbens core and shell lesions on intravenous heroin self-administration and the acquisition of drug-seeking behaviour under a second-order schedule of heroin reinforcement. Psychopharmacology (Berl.), 153, 464-472.
99. Ikemoto, S., & Panksepp, J. (1999). The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to rewardseeking. Brain Research. Brain Research Reviews, 31, 6-41.
100. Ito, R., Dalley, J. W., Howes, S. R., Robbins, T. W., & Everitt, B. J. (2000). Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. The Journal of Neuroscience, 20, 7489-7495.
101. Jakob, H., & Beckmann, H. (1986). Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65, 303-326.
102. Janowsky, D. S., & Davis, J. M. (1976). Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Archives of General Psychiatry, 33, 304-308.
103. Jeanblanc, J., Hoeltzel, A., & Louilot, A. (2003). Differential involvement of dopamine in the anterior part and posterior parts of the striatum in latent inhibition. Neuroscience, 118, 233-241.
104. Jeanblanc, J., Hoeltzel, A., & Louilot, A. (2002). Dissociation in the involvement of dopaminergic neurons innervating the core and shell subregions of the nucleus accumbens in latent inhibition and affective perception. Neuroscience, 111, 315-323.
105. Jeanblanc, J., Peterschmitt, Y., Hoeltzel, A., & Louilot, A. (2004). Influence of the entorhinal cortex on accumbal and striatal dopaminergic responses in a latent inhibition paradigm. Neuroscience, 128, 187-200.
106. Joel, D., Weiner, I., & Feldon, J. (1997). Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: Implications for animal models of schizophrenia. Behavioural Brain Research, 85, 187-201.
107. Jongen-Relo, A. L., Kaufmann, S., & Feldon, J. (2002). A differential involvement of the shell and core subterritories of the nucleus accumbens of rats in attentional processes. Neuroscience, 111, 95-109.
108. Joseph, M. H., Peters, S. L., Moran, P. M., et al. (2000). Modulation of latent inhibition in the rat by altered dopamine transmission in the nucleus accumbens at the time of conditioning. Neuroscience, 101, 921-930.
109. Kapur, S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. The American Journal of Psychiatry, 160, 13-23.
110. Kapur, S., Mizrahi, R., & Li, M. (2005). From dopamine to salience to psychosis - linking biology, pharmacology and phenomenology of psychosis. Schizophrenia Research, 79, 59-68.
111. Kaye, H., & Pearce, J. M. (1987a). Hippocampal lesions attenuate latent inhibition and the decline of the orienting response in rats. The Quarterly Journal of Experimental Psychology. B, Comparative and Physiological Psychology, 39, 107-125.
112. Kaye, H., & Pearce, J. M. (1987b). Hippocampal lesions attenuate latent inhibition of a CS and of a neutral stimulus. Psychobiology, 15, 293-299.
113. Kelley, A. E., Smith-Roe, S. L., & Holahan, M. R. (1997). Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proceedings of the National Academy of Sciences of the United States of America, 94, 12174-12179.
114. Kesner, R. P. (2000). Subregional analysis of mnemonic functions of the prefrontal cortex in the rat. Psychobiology, 28, 219-228.
115. Killcross, A. S., Dickinson, A., & Robbins, T. W. (1994a). Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology (Berl.), 115, 185-195.
116. Killcross, A. S., Dickinson, A., & Robbins, T. W. (1994b). Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms: evidence for dopamine-reinforcer interactions. Psychopharmacology (Berl.), 115, 196-205.
117. Killcross, A. S., & Robbins, T.W. (1993). Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology (Berl.), 110, 479-489.
118. Kinon, B. J., & Lieberman, J. A. (1996). Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl.), 124, 2-34.
119. Kolb, B. (1984). Functions of the frontal cortex of the rat: a comparative review. Brain Research, 320, 65-98.
120. Konstandi, M., & Kafetzopoulos, E. (1993). Effects of striatal or accumbens lesions on the amphetamine-induced abolition of latent inhibition. Pharmacology, Biochemistry, and Behavior, 44, 751-754.
121. Koob, G. F., Riley, S. J., Smith, S. C., & Robbins, T.W. (1978). Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. Journal of Comparative and Physiological Psychology, 92, 917-927.
122. Kornetsky, C. (1972). The use of a simple test of attention as a measure of drug effects in schizophrenic patients. Psychopharmacologia, 24, 99-106.
123. Kovelman, J. A., & Scheibel, A. B. (1984). A neurohistological correlate of schizophrenia. Biological Psychiatry, 19, 1601-1621.
124. Kraepeline, E. (1919). Dementia Praecox and Paraphrenia. New York: Kreiger.
125. Krystal, J. H., D'Souza, D. C., Mathalon, D., et al. (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl.), 169, 215-233.
126. Lacroix, L., Broersen, L. M., Feldon, J., & Weiner, I. (2000). Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behavioural Brain Research, 107, 111-121.
127. Lacroix, L., Broersen, L. M., Weiner, I., & Feldon, J. (1998). The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience, 84, 431-442.
128. Lacroix, L., Spinelli, S., White, W., & Feldon, J. (2000). The effects of ibotenic acid lesions of the medial and lateral prefrontal cortex on latent inhibition, prepulse inhibition and amphetamine-induced hyperlocomotion. Neuroscience, 97, 459-468.
129. Le Moal, M., & Simon, H. (1991). Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Physiological Reviews, 71, 155-234.
130. LeDoux, J. E. (1992). Brain mechanisms of emotion and emotional learning. Current Opinion in Neurobiology, 2, 191-197.
131. Lewis, M. C., & Gould, T. J. (2007a). Reversible inactivation of the entorhinal cortex disrupts the establishment and expression of latent inhibition of cued fear conditioning in C57BL/6 mice. Hippocampus, 17, 462-470.
132. Lewis, M. C., & Gould, T. J. (2007b). Signal transduction mechanisms within the entorhinal cortex that support latent inhibition of cued fear conditioning. Neurobiology of Learning and Memory, 88, 359-368.
133. Lieberman, J. A., Kane, J.M.,&Alvir, J. (1987). Provocative testswith psychostimulant drugs in schizophrenia. Psychopharmacology (Berl.), 91, 415-433.
134. Lieberman, J. A., Kane, J.M., Gadaleta, D., et al. (1984). Methylphenidate challenge as a predictor of relapse in schizophrenia. The American Journal of Psychiatry, 141, 633-638.
135. Lipp, O. V., & Vaitl, D. (1992). Latent inhibition in human Pavlovian differential conditioning - effect of additional stimulation after preexposure and relation to schizotypal traits. Personality and Individual Differences, 13, 1003-1012.
136. Louilot, A., & Besson, C. (2000). Specificity of amygdalostriatal interactions in the involvement of mesencephalic dopaminergic neurons in affective perception. Neuroscience, 96, 73-82.
137. Lubow, R. E. (1973). Latent inhibition. Psychological Bulletin, 79, 398-407.
138. Lubow, R. E. (1989). Latent Inhibition and Conditioned Attention Theory. New York: Cambridge University Press.
139. Lubow, R. E. (2005). Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophrenia Bulletin, 31, 139-153.
140. Lubow, R. E., & De la Casa, G. (2002). Latent inhibition as a function of schizotypality and gender: implications for schizophrenia. Biological Psychiatry, 59, 69-86.
141. Lubow, R. E., & Gewirtz, J. C. (1995). Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychological Bulletin. 117(1), 87-103.
142. Lubow, R. E., Ingberg-Sachs, Y., Zalstein-Orda, N., & Gewirtz, J. C. (1992). Latent inhibition in low and high "psychotic-prone" normal subjects. Personality and Individual Differences, 13, 563-572.
143. Lubow, R. E., Kaplan, O., Abramovich, P., Rudnick, A., & Laor, N. (2000). Visual search in schizophrenia: latent inhibition and novel pop-out effects. Schizophrenia Research, 45, 145-156.
144. Lubow, R. E., Kaplan, O., & De la Casa, G. (2001). Performance on the visual search analog of latent inhibition is modulated by an interaction between schizotypy and gender. Schizophrenia Research, 52, 275-287.
145. Lubow, R. E., Weiner, I., Schlossberg, A., & Baruch, I. (1987). Latent inhibition and schizophrenia. Bulletin of Psychonomic Society, 25, 464-467.
146. Lubow, R. E., Weiner, I., & Schnur, P. (1981). Conditioned attention theory. In G. H. Bower (Ed.), The Psychology of Learning and Motivation, vol. 15. New York: Academic Press, pp. 1-49.
147. Lyon, M. (1991). Animal models of mania and schizophrenia. In P. Willner (Ed.), Behavioral Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives. Cambridge: Cambridge University Press, pp. 253-310.
148. Mackintosh, N. J. (1975). A theory of attention: variations in the associability of stimuli with reinforcement. Psychological Review, 82, 276-298.
149. Magaro, P. A. (1980). Cognition in Schizophrenia and Paranoia: The Integration of Cognitive Processes. Hillsdale, NJ: Erlbaum.
150. Maher, B. A., Manschreck, T. C., & Molino, M. A. (1983). Redundancy, pause distributions and thought disorder in schizophrenia. Language and Speech, 26, 191-199.
151. Maldonado-Irizarry, C. S., & Kelley, A. E. (1994). Differential behavioral effects following microinjection of an NMDA antagonist into nucleus accumbens subregions. Psychopharmacology (Berl.), 116, 65-72.
152. Maldonado-Irizarry, C. S., & Kelley, A. E. (1995). Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat. Brain Research Bulletin, 38, 551-559.
153. Malkova, L., Gaffan, D., & Murray, E. A. (1997). Excitotoxic lesions of the amygdala fail to produce impairment in visual learning for auditory secondary reinforcement but interfere with reinforcer devaluation effects in rhesus monkeys. The Journal of Neuroscience, 17, 6011-6020.
154. Marcus, M. M., Nomikos, G. G., & Svensson, T. H. (2000). Effects of atypical antipsychotic drugs on dopamine output in the shell and core of the nucleus accumbens: role of 5-HT(2A) and alpha(1)-adrenoceptor antagonism. European Neuropsychopharmacology, 10, 245-253.
155. Maren, S., & Holt, W. (2000). The hippocampus and contextual memory retrieval in Pavlovian conditioning. Behavioural Brain Research, 110, 97-108.
156. McAlonan, K., & Brown, V. J. (2003). Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behavioural Brain Research, 146, 97-103.
157. McCartan, D., Bell, R., Green, J. F., et al. (2001). The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers. Journal of Psychopharmacology, 15, 96-104.
158. McGhie, A., & Chapman, J. (1961). Disorders of attention and perception in early schizophrenia. The British Journal of Medical Psychology, 34, 103-116.
159. Meltzer, H. Y., & Stahl, S. M. (1976). The dopamine hypothesis of schizophrenia: a review. Schizophrenia Bulletin, 2, 19-76.
160. Mizumori, S. J., Yeshenko, O., Gill, K.M., & Davis, D. M. (2004). Parallel processing across neural systems: implications for a multiple memory system hypothesis. Neurobiology of Learning and Memory, 82, 278-298.
161. Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. The Journal of Neuroscience, 17, 2921-2927.
162. Moore, H., Fadel, J., Sarter, M., & Bruno, J. P. (1999). Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience, 88, 811-822.
163. Moore, J. W., & Stickney, K. J. (1980). Formation of attentional-associative networks in real time: role of the hippocampus and implications for conditioning. Physiological Psychology, 8, 207-217.
164. Moran, P. M., Fischer, T. R., Hitchcock, J. M., & Moser, P. C. (1996). Effects of clozapine on latent inhibition in the rat. Behavioural Pharmacology, 7, 42-48.
165. Morgan, M. A., & LeDoux, J. E. (1995). Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behavioral Neuroscience, 109, 681-688.
166. Moser, P. C., Hitchcock, J. M., Lister, S., & Moran, P. M. (2000). The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Research. Brain Research Reviews, 33, 275-307.
167. Mulder, A. B., Hodenpijl, M. G., & Lopes da Silva, F. H. (1998). Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. The Journal of Neuroscience, 18, 5095-5102.
168. Murphy, C. A., Pezze, M., Feldon, J., & Heidbreder, C. (2000). Differential involvement of dopamine in the shell and core of the nucleus accumbens in the expression of latent inhibition to an aversively conditioned stimulus. Neuroscience, 97, 469-477.
169. Nuechterlein, K. H., & Dawson, M. E. (1984). Information processing and attentional functioning in the developmental course of schizophrenic disorders. Schizophrenia Bulletin, 10, 160-203.
170. O'Donnell, P., & Grace, A. A. (1998). Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophrenia Bulletin, 24, 267-283.
171. Oades, R. D. (1982). Attention and Schizophrenia:Neurobiological Bases. London: Pitman.
172. Oades, R. D. (1985). The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neuroscience & Biobehavioral Reviews, 9, 261-282.
173. Oswald, C. J., Yee, B. K., Rawlins, J. N., et al. (2002). The influence of selective lesions to components of the hippocampal system on the orienting [correction of orientating] response, habituation and latent inhibition. European Journal of Neuroscience, 15, 1983-1990.
174. Otake, K., & Nakamura, Y. (2000). Possible pathways through which neurons of the shell of the nucleus accumbens influence the outflow of the core of the nucleus accumbens. Brain and Development, 22, S17-26.
175. Parkinson, J. A., Cardinal, R. N., & Everitt, B. J. (2000). Limbic cortical-ventral striatal systems underlying appetitive conditioning. Progress in Brain Research, 126, 263-285.
176. Parkinson, J. A., Olmstead, M. C., Burns, L. H., Robbins, T. W., & Everitt, B. J. (1999). Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. The Journal of Neuroscience, 19, 2401-2411.
177. Payne, R. W. (1966). The measurement and significance of overinclusive thinking and retardation in schizophrenic patients. In P. Hoch & J. Zubin (Eds.), Psychopathology of Schizophrenia. New York: Grune and Stratton.
178. Pearce, J. M., & Hall, G. (1980). A model for Pavlovian learning: variations in the effectiveness of conditioned but not of unconditioned stimuli. Psychological Review, 87, 532-552.
179. Pennartz, C.M., Groenewegen, H. J., & Lopes da Silva, F. H. (1994). The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Progress in Neurobiology, 42, 719-761.
180. Peters, S. L., & Joseph, M. H. (1993). Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure. Behavioural Pharmacology, 4, 183-186.
181. Peterschmitt, Y., Hoeltzel, A., & Louilot, A. (2005). Striatal dopaminergic responses observed in latent inhibition are dependent on the hippocampal ventral subicular region. The European Journal of Neuroscience, 22, 2059-2068.
182. Peterschmitt, Y., Meyer, F., & Louilot, A. (2008). Differential influence of the ventral subiculum on dopaminergic responses observed in core and dorsomedial shell subregions of the nucleus accumbens in latent inhibition. Neuroscience, 154, 898-910.
183. Phillips, A. G., Ahn, S., & Howland, J. G. (2003). Amygdalar control of the mesocorticolimbic dopamine system: parallel pathways to motivated behavior. Neuroscience & Biobehavioral Reviews, 27, 543-554.
184. Pickens, C. L., Saddoris, M. P., Setlow, B., et al. (2003). Different roles for orbitofrontal cortex and basolateral amygdala in a reinforcer devaluation task. The Journal of Neuroscience, 23, 11078-11084.
185. Pouzet, B., Veenman, C. L., Yee, B. K., Feldon, J., & Weiner, I. (1999). The effects of radiofrequency lesion or transection of the fimbria-fornix on latent inhibition in the rat. Neuroscience, 91, 1355-1368.
186. Pouzet, B., Zhang, W. N., Weiner, I., Feldon, J., & Yee, B. K. (2004). Latent inhibition is spared by N-methyl-D-aspartate (NMDA)-induced ventral hippocampal lesions, but is attenuated following local activation of the ventral hippocampus by intracerebral NMDA infusion. Neuroscience, 124, 183-194.
187. Purves, D., Bonardi, C., & Hall, G. (1995). Enhancement of latent inhibition in rats with electrolytic lesions of the hippocampus. Behavioral Neuroscience, 109, 366-370.
188. Ragozzino, M. E., Detrick, S., & Kesner, R. P. (1999). Involvement of the prelimbicinfralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. The Journal of Neuroscience, 19, 4585-4594.
189. Ragozzino, M. E., Wilcox, C., Raso, M., & Kesner, R. P. (1999). Involvement of rodent prefrontal cortex subregions in strategy switching. Behavioral Neuroscience, 113, 32-41.
190. Rappaport, M., Silverman, J., Hopkins, H. K., & Hall, K. (1971). Phenothiazine effects on auditory signal detection in paranoid and nonparanoid schizophrenics. Science, 174, 723-725.
191. Rascle, C., Mazas, O., Vaiva, G., et al. (2001). Clinical features of latent inhibition in schizophrenia. Schizophrenia Research, 51, 149-161.
192. Redgrave, P., Prescott, T. J., & Gurney, K. (1999). The basal ganglia: a vertebrate solution to the selection problem? Neuroscience, 89, 1009-1023.
193. Reilly, S., Harley, C., & Revusky, S. (1993). Ibotenate lesions of the hippocampus enhance latent inhibition in conditioned taste aversion and increase resistance to extinction in conditioned taste preference. Behavioral Neuroscience, 107, 996-1004.
194. Restivo, L., Passino, E., Middei, S., & Ammassari-Teule, M. (2002). The strainspecific involvement of nucleus accumbens in latent inhibition might depend on differences in processing configural- and cue-based information between C57BL/6 and DBA mice. Brain Research Bulletin, 57, 35-39.
195. Robbins, T. W., Cador, M., Taylor, J. R., & Everitt, B. J. (1989). Limbic-striatal interactions in reward-related processes. Neuroscience & Biobehavioral Reviews, 13, 155-162.
196. Robbins, T. W., & Everitt, B. J. (1982). Functional studies of the central catecholamines. International Review of Neurobiology, 23, 303-365.
197. Robbins, T. W., & Everitt, B. J. (1996). Neurobehavioural mechanisms of reward and motivation. Current Opinion in Neurobiology, 6, 228-236.
198. Rolls, E. T. (1996). The orbitofrontal cortex. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 351, 1433-1443; discussion 1443-1434.
199. Rolls, E. T. (1999). The Brain and Emotion. Oxford: Oxford University Press.
200. Rolls, E. T. (2000a). Neurophysiology and functions of the primate amygdala, and the neural basis of emotion. In J. P. Aggleton (Ed.), The Amygdala: A Functional Analysis. New York: Oxford University Press, pp. 447-478.
201. Rolls, E. T. (2000b). The orbitofrontal cortex and reward. Cerebral Cortex, 10, 284-294.
202. Romano, A. G. (1999). Variations in CS associability and multiple unit hippocampal activity in the rabbit. Behavioural Brain Research, 103, 163-173.
203. Ruob, C., Elsner, J., Weiner, I., & Feldon, J. (1997). Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus. Behavioural Brain Research, 88, 35-41.
204. Salafia, W. R., & Allan, A. M. (1980). Attenuation of latent inhibition by electrical stimulation of hippocampus. Physiology and Behavior, 24, 1047-1051.
205. Salafia, W. R., & Allan, A.M. (1982). Augmentation of latent inhibition by electrical stimulation of hippocampus. Physiology and Behavior, 29, 1125-1130.
206. Salgado, J. V., Hetem, L. A., Vidal, M., et al. (2000). Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans. Behavioural Brain Research, 117, 61-67.
207. Schauz, C., & Koch, M. (2000). Blockade of NMDA receptors in the amygdala prevents latent inhibition of fear-conditioning. Learning and Memory, 7, 393-399.
208. Schiller, D., & Weiner, I. (2004). Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition in rats. Neuroscience, 128, 15-25.
209. Schiller, D., & Weiner, I. (2005). Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift. Behavioural Brain Research, 163, 115-121.
210. Schmajuk, N. A., Buhusi, C. V., & Gray, J. A. (1998). Psychopharmacology of latent inhibition: a neural network approach. Behavioural Pharmacology, 9, 711-730.
211. Schmajuk, N. A., Cox, L., & Gray, J. A. (2001). Nucleus accumbens, entorhinal cortex and latent inhibition: a neural network model. Behavioural Brain Research, 118, 123-141.
212. Schmajuk, N. A., Gray, J. A., & Lam, Y. W. (1996). Latent inhibition: a neural network approach. Journal of Experimental Psychology. Animal Behavior Processes, 22, 321-349.
213. Schmajuk, N. A., Lam, Y. W., & Christiansen, B. A. (1994). Latent inhibition of the rat eyeblink response: effect of hippocampal aspiration lesions. Physiology and Behavior, 55, 597-601.
214. Schmajuk, N. A., & Moore, J. W. (1985). Real-time attentional models for classical conditioning and the hippocampus. Physiological Psychology, 13, 278-290.
215. Schmajuk, N. A., & Moore, J. W. (1988). The hippocampus and the classically conditioned nictitating membrane response: a realtime attentional-associative model. Psychobiology, 16, 20-35.
216. Schoenbaum, G., Nugent, S. L., Saddoris, M. P., & Setlow, B. (2002). Orbitofrontal lesions in rats impair reversal but not acquisition of go, no-go odor discriminations. Neuroreport, 13, 885-890.
217. Schoenbaum, G., & Setlow, B. (2001). Integrating orbitofrontal cortex into prefrontal theory: common processing themes across species and subdivisions. Learning and Memory, 8, 134-147.
218. Schoenbaum, G., Setlow, B., Nugent, S. L., Saddoris, M. P., & Gallagher, M. (2003). Lesions of orbitofrontal cortex and basolateral amygdala complex disrupt acquisition of odor-guided discriminations and reversals. Learning and Memory, 10, 129-140.
219. Schultz, W. (1998). Predictive reward signal of dopamine neurons. Journal of Neurophysiology, 80, 1-27.
220. Seillier, A., Dieu, Y., Herbeaux, K., et al. (2007). Evidence for a critical role of entorhinal cortex at pre-exposure for latent inhibition disruption in rats. Hippocampus, 17, 220-226.
221. Setlow, B., Gallagher, M., & Holland, P. C. (2002). The basolateral complex of the amygdala is necessary for acquisition but not expression of CS motivational value in appetitive Pavlovian second-order conditioning. European Journal of Neuroscience, 15, 1841-1853.
222. Shadach, E., Feldon, J., & Weiner, I. (1999). Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. The International Journal of Neuropsychopharmacology, 2, 283-291.
223. Shakow, D. (1962). Segmental set. Archives of General Psychiatry, 6, 1-17.
224. Shohamy, D., Allen, M. T., & Gluck, M. A. (2000). Dissociating entorhinal and hippocampal involvement in latent inhibition. Behavioral Neuroscience, 114, 867-874.
225. Smith, A., Li, M., Becker, S., & Kapur, S. (2006). Dopamine, prediction error and associative learning: a model-based account. Network, 17, 61-84.
226. Smith-Roe, S. L., & Kelley, A. E. (2000). Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. The Journal of Neuroscience, 20, 7737-7742.
227. Snyder, S. H. (1973). Amphetamine psychosis: A "model" schizophrenia mediated by catecholamines. The American Journal of Psychiatry, 130, 61-67.
228. Snyder, S. H. (1976). The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. The American Journal of Psychiatry, 133, 197-202.
229. Solomon, P. R., Crider, A., Winkelman, J. W., et al. (1981). Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biological Psychiatry, 16, 519-537.
230. Solomon, P. R., & Moore, J. W. (1975). Latent inhibition and stimulus generalization of the classically conditioned nictitating membrane response in rabbits (Oryctolagus cuniculus) following dorsal hippocampal ablation. Journal of Comparative and Physiological Psychology, 89, 1192-1203.
231. Solomon, P. R., & Staton, D. M. (1982). Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biological Psychiatry, 17, 743-756.
232. Stahl, S. M. (1988). Basal ganglia neuropharmacology and obsessive-compulsive disorder: the obsessive-compulsive disorder hypothesis of basal ganglia dysfunction. Psychopharmacology Bulletin, 24, 370-374.
233. Swanson, C. J., Heath, S., Stratford, T. R., & Kelley, A. E. (1997). Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacology, Biochemistry, and Behavior, 58, 933-945.
234. Swerdlow, N. R., Braff, D. L., Hartston, H., Perry, W., & Geyer, M. A. (1996). Latent inhibition in schizophrenia. Schizophrenia Research, 20, 91-103.
235. Swerdlow, N. R., & Koob, G. F. (1987). Dopamine, schizophrenia, mania and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behavioral and Brain Sciences, 10, 197-245.
236. Swerdlow, N. R., Stephany, N., Wasserman, L. C., et al. (2003). Dopamine agonists disrupt visual latent inhibition in normal males using a within-subject paradigm. Psychopharmacology (Berl.), 169, 314-320.
237. Taghzouti, K., Louilot, A., Herman, J. P., Le Moal, M., & Simon, H. (1985). Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat. Behavioral and Neural Biology, 44, 354-363.
238. Taghzouti, K., Simon, H., Louilot, A., Herman, J. P., & Le Moal, M. (1985). Behavioral study after local injection of 6-hydroxydopamine into the nucleus accumbens in the rat. Brain Research, 344, 9-20.
239. Tai, C. T., Cassaday, H. J., Feldon, J., & Rawlins, J. N. (1995). Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition of learning in rats. Neurobiology of Learning and Memory, 64, 36-48.
240. Thornton, J. C., Dawe, S., Lee, C., et al. (1996). Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology (Berl.), 127, 164-173.
241. Trimble, K. M., Bell, R., & King, D. J. (1997). Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride. Pharmacology, Biochemistry, and Behavior, 56, 809-816.
242. Trimble, K. M., Bell, R., & King, D. J. (1998). Enhancement of latent inhibition in the rat at a high dose of clozapine. Journal of Psychopharmacology, 12, 215-219.
243. Trimble, K. M., Bell, R., & King, D. J. (2002). Effects of the selective dopamine D(1) antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat. Physiology and Behavior, 77, 115-123.
244. Vaitl, D., & Lipp, O. V. (1997). Latent inhibition and autonomic responses: a psychophysiological approach. Behavioural Brain Research, 88, 85-93.
245. Vaitl, D., Lipp, O., Bauer, U., et al. (2002). Latent inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. Schizophrenia Research, 55, 147-158.
246. van den Bos, R., Charria Ortiz, G. A., Bergmans, A. C., & Cools, A. R. (1991). Evidence that dopamine in the nucleus accumbens is involved in the ability of rats to switch to cue-directed behaviours. Behavioural Brain Research, 42, 107-114.
247. van den Bos, R., & Cools, A. R. (1989). The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviours. Life Sciences, 44, 1697-1704.
248. van Kammen, D. P., Bunney, W.E., Jr., Docherty, J. P., et al. (1982). d-Amphetamineinduced heterogeneous changes in psychotic behavior in schizophrenia. The American Journal of Psychiatry, 139, 991-997.
249. Venables, P. H. (1984). Cerebral mechanisms, autonomic responsiveness, and attention in schizophrenia. Nebraska Symposium on Motivation, 31, 47-91.
250. Wagner, A. R., & Rescorla, R. A. (1972). Inhibition in Pavlovian conditioning: Application of a theory. In R. A. Boakes & M. A. Halliday (Eds.), Inhibition and Learning. New York: Academic Press.
251. Warburton, E. C., Joseph, M. H., Feldon, J., Weiner, I., & Gray, J. A. (1994). Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron. Psychopharmacology (Berl.), 114, 657-664.
252. Warburton, E. C., Mitchell, S. N., & Joseph, M. H. (1996). Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition. Behavioural Pharmacology, 7, 119-129.
253. Weiner, I. (1990). Neural substrates of latent inhibition: the switching model. Psychological Bulletin, 108, 442-461.
254. Weiner, I. (2000). The latent inhibition model of schizophrenia. InM. S.Myslobodsky& I.Weiner (Eds.), Contemporary Issues in Modeling Psychopathology. Dordrecht: Kluwer Academic, pp. 197-230.
255. Weiner, I. (2001). Latent inhibition. In J. N. Crawley, C. R. Gerfen, M. A. Rogawski, D. R. Sibley, P. Skolnick & S. Wray (Eds.), Current Protocols in Neuroscience, vol. 8.13. New York: John Wiley & Sons.
256. Weiner, I. (2003). The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl.), 169, 257-297.
257. Weiner, I., Bernasconi, E., Broersen, L. M., & Feldon, J. (1997). Amphetamineinduced disruption of latent inhibition depends on the nature of the stimulus. Behavioural Pharmacology, 8, 442-457.
258. Weiner, I., & Feldon, J. (1987). Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology (Berl.), 91, 248-253.
259. Weiner, I., & Feldon, J. (1997). The switching model of latent inhibition: an update of neural substrates. Behavioural Brain Research, 88, 11-25.
260. Weiner, I., Feldon, J., & Katz, Y. (1987). Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacology, Biochemistry, and Behavior, 26, 241-246.
261. Weiner, I., Feldon, J., Tarrasch, R., Hairston, I., & Joel, D. (1998). Fimbria-fornix cut affects spontaneous activity, two-way avoidance and delayed non matching to sample, but not latent inhibition. Behavioural Brain Research, 96, 59-70.
262. Weiner, I., Gaisler, I., Schiller, D., et al. (2000). Screening of antipsychotic drugs in animal models. Drug Development Research, 50, 235-249.
263. Weiner, I., Gal, G., & Feldon, J. (1999). Disrupted and undisruptable latent inhibition following shell and core lesions. Annals of the New York Academy of Sciences, 877, 723-727.
264. Weiner, I., Gal, G., Rawlins, J. N., & Feldon, J. (1996a). Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behavioural Brain Research, 81, 123-133.
265. Weiner, I., & Joel, D. (2002). Dopamine in schizophrenia: dysfunctional information processing in basal ganglia-thalamocortical split circuits. In G. Di Chiara (Ed.), Handbook of Experimental Pharmacology, vol. 54/II, Dopamine in the CNS II. Berlin: Springer, pp. 418-472.
266. Weiner, I., Lubow, R. E., & Feldon, J. (1981). Chronic amphetamine and latent inhibition. Behavioural Brain Research, 2, 285-286.
267. Weiner, I., Lubow, R. E., & Feldon, J. (1984). Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology (Berl.), 83, 194-199.
268. Weiner, I., Lubow, R. E., & Feldon, J. (1988). Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacology, Biochemistry, and Behavior, 30, 871-878.
269. Weiner, I., Shadach, E., Barkai, R., & Feldon, J. (1997). Haloperidol- and clozapineinduced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology, 16, 42-50.
270. Weiner, I., Shadach, E., Tarrasch, R., Kidron, R., & Feldon, J. (1996b). The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biological Psychiatry, 40, 834-843.
271. Weiner, I., Tarrasch, R., Bernasconi, E., et al. (1997). Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. Pharmacology, Biochemistry, and Behavior, 56, 817-826.
272. Weiner, I., Tarrasch, R., & Feldon, J. (1995). Basolateral amygdala lesions do not disrupt latent inhibition. Behavioural Brain Research, 72, 73-81.
273. Westbrook, R. F., Jones, M. L., Bailey, G. K., & Harris, J. A. (2000). Contextual control over conditioned responding in a latent inhibition paradigm. Journal of Experimental Psychology. Animal Behavior Processes, 26, 157-173.
274. Wheeler, D. S., Chang, R. C., & Miller, R. R. (2003). Massive preexposure and preexposure in multiple contexts attenuate the context specificity of latent inhibition. Learning and Behavior, 31, 378-386.
275. Williams, J. H., Wellman, N. A., Geaney, D. P., et al. (1996). Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people. Biological Psychiatry, 40, 1135-1143.
276. Williams, J. H., Wellman, N. A., Geaney, D. P., et al. (1997). Haloperidol enhances latent inhibition in visual tasks in healthy people. Psychopharmacology (Berl.), 133, 262-268.
277. Williams, J. H., Wellman, N. A., Geaney, D. P., et al. (1998). Reduced latent inhibition in people with schizophrenia: an effect of psychosis or of its treatment. The British Journal of Psychiatry, 172, 243-249.
278. Wuthrich, V., & Bates, T. C. (2001). Schizotypy and latent inhibition: non-linear linkage between psychometric and cognitive markers. Personality and Individual Differences, 30, 783-798.
279. Yap, C. S., & Richardson, R. (2005). Latent inhibition in the developing rat: an examination of context-specific effects. Developmental Psychobiology, 47, 55-65.
280. Yee, B. K., Feldon, J., & Rawlins, J. N. (1995). Latent inhibition in rats is abolished by NMDA-induced neuronal loss in the retrohippocampal region, but this lesion effect can be prevented by systemic haloperidol treatment. Behavioral Neuroscience, 109, 227-240.
281. Yee, B. K., Feldon, J., & Rawlins, J. N. (1997). Cytotoxic lesions of the retrohippocampal region attenuate latent inhibition but spare the partial reinforcement extinction effect. Experimental Brain Research, 115, 247-256.
282. Young, A. M., Joseph, M. H., & Gray, J. A. (1993). Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience, 54, 5-9.
283. Zahm, D. S. (1999). Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Annals of the New York Academy of Sciences, 877, 113-128.
284. Zahm, D. S. (2000). An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens. Neuroscience & Biobehavioral Reviews, 24, 85-105.
285. Zahm, D. S., & Brog, J. S. (1992). On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience, 50, 751-767.
286. Zuckerman, L., Rimmerman, N., & Weiner, I. (2003). Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia. Psychopharmacology (Berl.), 169, 298-307.